Patent · US Active

Methods of human retinal progenitor cell isolation and culture

US12410398B2 · kind B2 · utility

0Cited by

1References

19Claims

0Family size

Assignee

The Regents of the University of California · US

Inventors

Jing Yang · Cambridge, US
Henry Klassen · Irvine, US

Key dates

Filing date	Sep 27, 2019
Grant date	Sep 9, 2025
Priority date	—
Expiry date	Jun 20, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2523/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.